what is the new glp 1 drug GLP-1 Guidelines for Type 2 Diabetes in 2025 Patent and Innovation Trends in

Growing Technological Developments in the Delivery and Formulation of Drugs The GLP-1 receptor agonist cardiovascular therapy market is mostly driven by technological developments in drug formulation and administration

Use of glucagon-Like-Peptide 1 receptor agonists and risk of fracture as compared to use of other anti-hyperglycemic drugs

: (-16 )

Bidirectional relationships and disconnects between NAFLD and features of the metabolic syndrome

Dynamic chromatin remodeling in cycling human endometrium at single-cell level

Several meta-analyses found a link between resveratrol consumption and improvement of FMD, serum vascular adhesion molecules (ICAM-1), SBP, TC, fasting glucose, HbA1c, AST and ALT (Reference Abdelhaleem, Brakat and Adayel56Reference Soltani, Sharifi-Zahabi and Sangsefidi60)